ONCE YEARLY LENACAPAVIR
Dr Reddy's inks pact with Gilead for once-yearly HIV prevention drug lenacapavirDr Reddy's Laboratories and Gilead Sciences have signed a licensing agreement. This pact involves investigational once-yearly lenacapavir f...
Twice-yearly shot could help end AIDS. But will it get to everyone who needs it?Gilead's twice-yearly HIV prevention shot was 100% effective in women and almost as good in men. The company will offer cheap generic versi...
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'The shots made by U.S. drugmaker Gilead and sold as Sunlenca are approved in the U.S., Canada, Europe and elsewhere, but only as a treatmen...
HIV breakthrough: Drug trial shows injection twice a year is 100% effective against infectionThe trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs,...
Load More